Parkinson’s Disease: Understanding Complexity to Restore Quality of Life

From neurological progression to therapeutic innovation: a new era in patient-centered care

April invites us to pause and engage in a conversation that still requires greater visibility, deeper understanding, and, above all, greater humanity: Parkinson’s disease.

Every April 11 marks World Parkinson’s Day—a date that goes beyond awareness and becomes a call to recognize a condition that impacts not only the patient, but also their autonomy, identity, and daily life.

A Growing Global Condition

Parkinson’s disease is currently the second most common neurodegenerative disorder worldwide, following Alzheimer’s disease.

It is estimated that between 4.1 and 4.6 million people over the age of 50 are living with Parkinson’s, and projections suggest this number could double by 2030.

More than a statistic, this represents an expanding challenge for healthcare systems and for how we understand aging.

In Mexico, while comprehensive epidemiological data is still limited, the estimated incidence is 40 to 50 cases per 100,000 people per year, reinforcing the need for early diagnosis and timely intervention.

Beyond Tremors: The True Dimension of Parkinson’s

Parkinson’s disease is characterized by the progressive loss of neurons responsible for movement, coordination, and muscle tone. However, reducing it to a purely motor disorder would overlook its true complexity.

Yes, there are well-known motor symptoms such as:

• Bradykinesia (slowness of movement)
• Muscle rigidity
• Resting tremor
• Postural instability

But there is also a less visible and often more challenging dimension:

• Depression and anxiety
• Sleep disturbances
• Cognitive decline
• Fatigue
• Autonomic dysfunction

Parkinson’s does not only affect the body. It reshapes the lived experience of being.

The Challenge of Long-Term Treatment

Initial treatment for Parkinson’s typically focuses on pharmacological management, with levodopa as the cornerstone therapy.

Over time, however, treatment response may evolve.

Patients may experience:

• Dyskinesias (involuntary movements)
• Motor fluctuations
• Gastrointestinal and psychiatric side effects

This requires continuous adaptation of therapeutic strategies, tailored to disease progression and individual patient response.

When Medicine Advances: Deep Brain Stimulation

In this context, medical innovation has introduced new possibilities.

Deep Brain Stimulation (DBS) is now one of the most advanced treatment options for patients whose symptoms are no longer adequately controlled with medication.

This procedure involves implanting electrodes in specific areas of the brain, connected to a device that delivers high-frequency electrical impulses. These impulses modulate abnormal neural activity and help reduce motor symptoms such as:

• Tremor
• Rigidity
• Slowness of movement

When properly indicated and with appropriate patient selection, DBS can significantly improve quality of life.

Patient Selection: The Key to Success

Not all patients are candidates for this type of intervention.

The decision must be based on a multidisciplinary evaluation that considers:

• Prior response to medication
• Presence of motor fluctuations
• Functional impact of symptoms
• Cognitive and emotional status

This is where medicine moves from generalized care to highly individualized decision-making.

Toward a More Human Approach to Parkinson’s

Addressing Parkinson’s today means recognizing that the goal is not only to extend life, but to preserve its quality.

The integration of early diagnosis, pharmacological treatment, advanced medical technologies, and multidisciplinary care is allowing more patients to:

• maintain independence
• reduce the progression of disabling symptoms
• regain confidence in daily life

The future of Parkinson’s care lies not only in technology, but in how we integrate science, empathy, and clinical precision into every decision.

April: Beyond Awareness, Toward Action

Parkinson’s Awareness Month reminds us that information is only the beginning.

We need:

• open conversations
• earlier diagnoses
• access to advanced therapies
• and a more human-centered approach to care

Because behind every diagnosis, there is a life that deserves to be lived with dignity.